Delivery schedule
Latest information on the scheduled supply of our nuclear medicine production.
Showing 1 - 12 of 12 results
Latest information on the scheduled supply of our nuclear medicine production.
Over the past 70 years ANSTO has been building Australia’s nuclear expertise and despite being small in scale, today we are complex and sophisticated nuclear nation.
The Australian Nuclear Association (ANA) has awarded Lubi Dimitrovski, former Manager, ANSTO Waste Operations (1995-2012) and former General Manager Nuclear Operations (2013-2018), its Award for 2022 in recognition of his leadership role in radioactive waste management in Australia.
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
Planning is now underway for a second repatriation project which is scheduled to take place in 2022. Find out more information.
ANSTO announces the recipients of the 2022 organisational awards
In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.
Publications and resources from the Powder Diffraction beamline.